Seminars in Perinatology
Volume 34, Issue 2 , Pages 125-133 , April 2010

Improving and Assuring Newborn Screening Laboratory Quality Worldwide: 30-Year Experience at the Centers for Disease Control and Prevention

References 

  1. Guthrie R. The origin of newborn screening. Screening. 1992;1:5–15
  2. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics. 1963;32:338–343
  3. Scheel C, Berry HK. Comparison of serum phenylalanine levels with growth in Guthrie's inhibition assay in newborn infants. J Pediatr. 1962;61:610–616
  4. Newborn Screening Quality Assurance Program: Current reports. http://www.cdc.gov/labstandards/nsqap.htmAccessed September 28, 2009
  5. Belk WP, Sunderman FW. A survey of the accuracy of chemical analyses in clinical laboratories. Am J Clin Pathol. 1947;17:853–861
  6. Shahangian S. Proficiency testing in laboratory medicine: uses and limitations. Arch Pathol Lab Med. 1998;122:15–30
  7. Therrell BL, Hannon WH. National evaluation of US newborn screening system components. Ment Retard Dev Disabil Res Rev. 2006;12:236–245
  8. Simopoulos AP, Childs B. Genetic Screening: Programs, Principles, and Research. Washington, DC: National Academy of Sciences; 1975;
  9. Hannon WH, Whitley RJ, Davin B, et al. Blood Collection on Filter Paper for Newborn Screening Programs; Approved Standard––Fifth edition. Wayne, PA: Clinical Laboratory Standards Institute; 2007;CLSI document LA4-A5
  10. Gwinn M, Pappaioanou M, George JR, et al. Prevalence of HIV infection in childbearing women in the United States (Surveillance using newborn blood samples). JAMA. 1991;265:1704–1708
  11. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia (A randomized trial). N Engl J Med. 1986;314:1593–1599
  12. Centers for Disease Control and Prevention. Newborn screening for cystic fibrosis: a paradigm for public health genetics policy development—proceedings of a 1997 workshop. MMWR Recomm Rep. 1997;46(RR16):1–22
  13. Chace DH, Millington DS, Terada N, et al. Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry. Clin Chem. 1993;39:66–71
  14. Centers for Disease Control and Prevention. Using tandem mass spectrometry for metabolic disease screening among newborns: a report of a work group. MMWR Recomm Rep. 2001;50(RR03):1–22
  15. Watson MS, Mann M, Lloyd-Puryear MA, et al. Newborn screening: Toward a uniform screening panel and system. Genet Med. 2006;8:12S–252S
  16. Lacey JM, Minutti CZ, Magera MJ, et al. Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry. Clin Chem. 2004;50:621–625
  17. Chace DH, Lim T, Hansen CR, et al. Improved MS/MS analysis of succinylacetone extracted from dried blood spots when combined with amino acids and acylcarnitine butyl esters. Clin Chim Acta. 2009;407:6–9
  18. Magera MJ, Gunawardena ND, Hahn SH, et al. Quantitative determination of succinylacetone in dried blood spots for newborn screening of tyrosinemia type I. Mol Genet Metab. 2006;88:16–21
  19. De Jesus VR, Zhang XK, Keutzer J, et al. Development and evaluation of quality control dried blood spot materials in newborn screening for lysosomal storage disorders. Clin Chem. 2009;55:158–164
  20. De Jesus VR, Zhou H, Vogt RF, et al. Changes in solvent composition in tandem mass spectrometry multiplex assay for lysosomal storage disorders do not affect assay results. Clin Chem. 2009;55:596–598
  21. Jara M, Hsu HW, Eaton RB, et al. Epidemiology of congenital toxoplasmosis identified by population-based newborn screening in Massachusetts. Pediatr Infect Dis J. 2001;20:1132–1135
  22. Grosse SD, Dollard S, Ross DS, et al. Newborn screening for congenital cytomegalovirus: options for hospital-based and public health programs. J Clin Virol. 2009;46(suppl 4):S32–S36
  23. Faucher S, Martel A, Sherring A, et al. Protein bead array for the detection of HIV-1 antibodies from fresh plasma and dried-blood-spot specimens. Clin Chem. 2004;50:1250–1253
  24. Lukacs Z, Dietrich A, Ganschow R, et al. Simultaneous determination of HIV antibodies, hepatitis C antibodies, and hepatitis B antigens in dried blood spots––A feasibility study using a multi-analyte immunoassay. Clin Chem Lab Med. 2005;43:141–145
  25. Fair RB, Khlystov A, Tailor TD, et al. Chemical and biological applications of digital-microfluidic devices. IEEE Des Test Comput. 2007;24:10–24
  26. National Newborn Screening and Genetics Resource Center. http://genes-r-us.uthscsa.eduAccessed October 5, 2009
  27. Duffner PK, Caggana M, Orsini JJ, et al. Newborn screening for Krabbe disease: the New York State model. Pediatr Neurol. 2009;40:245–252
  28. Newborn Screening Saves Lives Act. http://www.govtrack.us/congress/bill.xpd?bill=s110-1858Accessed October 5, 2009

PII: S0146-0005(09)00108-6

doi: 10.1053/j.semperi.2009.12.003

Seminars in Perinatology
Volume 34, Issue 2 , Pages 125-133 , April 2010

Article Tools

* Image Usage & Resolution